Literature DB >> 19082784

Role of advanced MR imaging modalities in diagnosing cerebral gliomas.

T Scarabino1, T Popolizio, F Trojsi, G Giannatempo, S Pollice, N Maggialetti, A Carriero, A Di Costanzo, G Tedeschi, U Salvolini.   

Abstract

The objective of this study was to evaluate the potential role of newly developed, advanced magnetic resonance (MR) imaging techniques (spectroscopy, diffusion and perfusion imaging) in diagnosing brain gliomas, with special reference to histological typing and grading, treatment planning and posttreatment follow-up. Conventional MR imaging enables the detection and localisation of neoplastic lesions, as well as providing, in typical cases, some indication about their nature. However, it has limited sensitivity and specificity in evaluating histological type and grade, delineating margins and differentiating oedema, tumour and treatment side-effects. These limitations can be overcome by supplementing the morphological data obtained with conventional MR imaging with the metabolic, structural and perfusional information provided by new MR techniques that are increasingly becoming an integral part of routine MR studies. Incorporation of such new MR techniques can lead to more comprehensive and precise diagnoses that can better assist surgeons in determining prognosis and planning treatment strategies. In addition, the recent development of new, more effective, treatments for cerebral glioma strongly relies on morphofunctional MR imaging with its ability to provide a biological interpretation of these characteristically heterogeneous tumours.

Entities:  

Mesh:

Year:  2008        PMID: 19082784     DOI: 10.1007/s11547-008-0351-9

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  57 in total

Review 1.  Methodology of brain perfusion imaging.

Authors:  E L Barbier; L Lamalle; M Décorps
Journal:  J Magn Reson Imaging       Date:  2001-04       Impact factor: 4.813

2.  Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy.

Authors:  Alfonso Di Costanzo; Tommaso Scarabino; Francesca Trojsi; Giuseppe M Giannatempo; Teresa Popolizio; Domenico Catapano; Simona Bonavita; Nicola Maggialetti; Michela Tosetti; Ugo Salvolini; Vincenzo A d'Angelo; Giocchino Tedeschi
Journal:  Neuroradiology       Date:  2006-06-03       Impact factor: 2.804

3.  3.0-T morphological and angiographic brain imaging: a 5-years experience.

Authors:  T Scarabino; T Popolizio; G M Giannatempo; F Nemore; A Maiorana; A Carriero; D Messana; A Maggialetti; M Armillotta; U Salvolini
Journal:  Radiol Med       Date:  2007-02-22       Impact factor: 3.469

4.  Cerebral blood volume measurements and proton MR spectroscopy in grading of oligodendroglial tumors.

Authors:  M Vittoria Spampinato; J Keith Smith; Lester Kwock; Matthew Ewend; John D Grimme; Daniel L A Camacho; Mauricio Castillo
Journal:  AJR Am J Roentgenol       Date:  2007-01       Impact factor: 3.959

5.  Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery.

Authors:  E E Graves; S J Nelson; D B Vigneron; L Verhey; M McDermott; D Larson; S Chang; M D Prados; W P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2001-04       Impact factor: 3.825

6.  Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging.

Authors:  Bahattin Hakyemez; Cuneyt Erdogan; Naile Bolca; Nalan Yildirim; Gokhan Gokalp; Mufit Parlak
Journal:  J Magn Reson Imaging       Date:  2006-10       Impact factor: 4.813

7.  A preliminary study of the prognostic value of proton magnetic resonance spectroscopic imaging in gamma knife radiosurgery of recurrent malignant gliomas.

Authors:  E E Graves; S J Nelson; D B Vigneron; C Chin; L Verhey; M McDermott; D Larson; P K Sneed; S Chang; M D Prados; K Lamborn; W P Dillon
Journal:  Neurosurgery       Date:  2000-02       Impact factor: 4.654

8.  Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors.

Authors:  Nail Bulakbasi; Murat Kocaoglu; Fatih Ors; Cem Tayfun; Taner Uçöz
Journal:  AJNR Am J Neuroradiol       Date:  2003-02       Impact factor: 3.825

9.  Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected].

Authors:  Michael H Lev; Yelda Ozsunar; John W Henson; Amjad A Rasheed; Glenn D Barest; Griffith R Harsh; Markus M Fitzek; E Antonio Chiocca; James D Rabinov; Andrew N Csavoy; Bruce R Rosen; Fred H Hochberg; Pamela W Schaefer; R Gilberto Gonzalez
Journal:  AJNR Am J Neuroradiol       Date:  2004-02       Impact factor: 3.825

10.  Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors.

Authors:  Stanley Lu; Daniel Ahn; Glyn Johnson; Soonmee Cha
Journal:  AJNR Am J Neuroradiol       Date:  2003-05       Impact factor: 3.825

View more
  6 in total

1.  Recurrent glioblastoma multiforme versus radiation injury: a multiparametric 3-T MR approach.

Authors:  Alfonso Di Costanzo; Tommaso Scarabino; Francesca Trojsi; Teresa Popolizio; Simona Bonavita; Mario de Cristofaro; Renata Conforti; Adriana Cristofano; Claudio Colonnese; Ugo Salvolini; Gioacchino Tedeschi
Journal:  Radiol Med       Date:  2014-01-10       Impact factor: 3.469

2.  Diagnostic accuracy of proton magnetic resonance spectroscopy and perfusion-weighted imaging in brain gliomas follow-up: a single institutional experience.

Authors:  Monica Anselmi; Alessia Catalucci; Valentina Felli; Valentina Vellucci; Alessandra Di Sibio; Giovanni Luca Gravina; Mario Di Staso; Ernesto Di Cesare; Carlo Masciocchi
Journal:  Neuroradiol J       Date:  2017-01-01

3.  Advanced MRI may complement histological diagnosis of lower grade gliomas and help in predicting survival.

Authors:  Valeria Cuccarini; A Erbetta; M Farinotti; L Cuppini; F Ghielmetti; B Pollo; F Di Meco; M Grisoli; G Filippini; G Finocchiaro; M G Bruzzone; M Eoli
Journal:  J Neurooncol       Date:  2016-01       Impact factor: 4.130

4.  Novel membrane-permeable contrast agent for brain tumor detection by MRI.

Authors:  Mohanraja Kumar; Zdravka Medarova; Pamela Pantazopoulos; Guangping Dai; Anna Moore
Journal:  Magn Reson Med       Date:  2010-03       Impact factor: 4.668

5.  Differential diagnosis by unenhanced FLAIR T2-weighted magnetic resonance images between solitary high grade gliomas and cerebral metastases appearing as contrast-enhancing cortico-subcortical lesions.

Authors:  Carmine Franco Muccio; Annachiara Tarantino; Gennaro Esposito; Alfonso Cerase
Journal:  J Neurooncol       Date:  2010-11-11       Impact factor: 4.130

6.  Spectroscopic evaluation of glioma grading at 3T: the combined role of short and long TE.

Authors:  E Kousi; I Tsougos; E Tsolaki; K N Fountas; K Theodorou; I Fezoulidis; E Kapsalaki; C Kappas
Journal:  ScientificWorldJournal       Date:  2012-07-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.